NASDAQ:KEYS 31 July 2025

Keysight Shares Surge as Orders Hit Record High

Keysight Technologies shares gained in late trading Tuesday. The electronic test-equipment company reported fiscal second-quarter profit that beat forecasts, booked over $2 billion in orders, and signaled more growth is coming next quarter.

19 May 2026

Earnings·NASDAQ:KEYS·Stock Market·Technology

Keysight stock price surges after upbeat forecast; AI data-center demand puts KEYS in focus

Keysight Technologies shares jumped roughly 21% on Tuesday, trading near $296 after peaking at $301.48. The stock finished Monday at $245.

24 February 2026

NASDAQ:KEYS·Stock Market·Technology

Viavi Solutions (VIAV) stock slides 8% as it unveils Verizon-linked AR tool — what’s next

Viavi Solutions Inc shares fell about 8% to $17.03 in afternoon trading on Thursday, after touching a session low of $16.98. About 3.0 million shares had changed hands by 3:08 p.m. EST.

8 January 2026

NASDAQ:KEYS·NASDAQ:VIAV·NYSE:VZ·Stock Market

Quantum in Orbit, 100K-Qubit Ambitions & More – Quantum Computing Roundup (July 30–31, 2025)

From the first quantum computer in space to new funding fueling the industry, the past two days have delivered a whirlwind of quantum computing developments worldwide. Here’s a comprehensive roundup of all the notable quantum news from July 30–31, 2025, spanning breakthrough research, corporate moves, government action, and expert insights.

31 July 2025

NASDAQ:IONQ·NASDAQ:KEYS·Quantum Computing·TSX:9984

NASDAQ:KEYS 31 July 2025 - 19 May 2026

Keysight Shares Surge as Orders Hit Record High

Keysight stock price surges after upbeat forecast; AI data-center demand puts KEYS in focus

Viavi Solutions (VIAV) stock slides 8% as it unveils Verizon-linked AR tool — what’s next

Quantum in Orbit, 100K-Qubit Ambitions & More – Quantum Computing Roundup (July 30–31, 2025)

TechStock² Updates

S&P 500 Call-Put Ratio Hits Four-Year Bullish High as Index Eases and Upside Scope Tightens

Meta (NASDAQ:META) shares lose momentum as Muse enthusiasm faces $145 billion investment trial

Eli Lilly (NYSE:LLY) gains $30 billion following UK approval for Foundayo; NHS access remains pending

AbCellera (NASDAQ:ABCL) jumps 37.5% as hot-flash trial hits all main and secondary goals

Strategy Sells $653 Million in MSTR, Swells Cash Holdings Beyond Bitcoin Divestment

Top Stock Picks

Taiwan Semiconductor

AerCap

Constellation Energy

Walt Disney

American International Group

Live updates

Investment Disclaimer